Literature DB >> 18226949

Increase in sleep-related breathing disturbances after treatment with sodium oxybate in patients with narcolepsy and mild obstructive sleep apnea syndrome: two case reports.

M Seeck-Hirschner, P C Baier, A von Freier, J Aldenhoff, R Göder.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18226949     DOI： 10.1016/j.sleep.2007.11.018

Source DB:  PubMed          Journal:  Sleep Med        ISSN： 1389-9457            Impact factor:   3.492


× No keyword cloud information.
  9 in total

1.  Sodium oxybate and breathing.

Authors:  Juan Jose Ortega-Albas; Roberto López-Bernabé; Jose Ramón Diaz; Angel Luis Serrano
Journal:  Sleep Breath       Date:  2009-11-27       Impact factor: 2.816

Review 2.  Safety overview of postmarketing and clinical experience of sodium oxybate (Xyrem): abuse, misuse, dependence, and diversion.

Authors:  Y Grace Wang; Todd J Swick; Lawrence P Carter; Michael J Thorpy; Neal L Benowitz
Journal:  J Clin Sleep Med       Date:  2009-08-15       Impact factor: 4.062

3.  Catathrenia under sodium oxybate in narcolepsy with cataplexy.

Authors:  Francesca Poli; Lara Ricotta; Stefano Vandi; Christian Franceschini; Fabio Pizza; Vincenzo Palaia; Keivan Kaveh Moghadam; Donatella Banal; Roberto Vetrugno; Michael J Thorpy; Giuseppe Plazzi
Journal:  Sleep Breath       Date:  2011-04-12       Impact factor: 2.816

4.  Central Sleep Apnea With Sodium Oxybate in a Pediatric Patient.

Authors:  Arezou Heshmati
Journal:  J Clin Sleep Med       Date:  2019-03-15       Impact factor: 4.062

5.  Sodium oxybate and sleep apnea: a clinical case.

Authors:  Sarah Hartley; Maria-Antonia Quera-Salva; Mourad Machou
Journal:  J Clin Sleep Med       Date:  2011-12-15       Impact factor: 4.062

Review 6.  Can improving sleep influence sleep-disordered breathing?

Authors:  Frédéric Sériès
Journal:  Drugs       Date:  2009       Impact factor: 9.546

7.  Safety and efficacy of long-term use of sodium oxybate for narcolepsy with cataplexy in routine clinical practice.

Authors:  Panagis Drakatos; Dimosthenis Lykouras; Grainne D'Ancona; Sean Higgins; Nadia Gildeh; Raluca Macavei; Ivana Rosenzweig; Joerg Steier; Adrian J Williams; Rexford Muza; Brian D Kent; Guy Leschziner
Journal:  Sleep Med       Date:  2017-05-06       Impact factor: 3.492

Review 8.  Clinical perspective: monitoring sodium oxybate-treated narcolepsy patients for the development of sleep-disordered breathing.

Authors:  Neil T Feldman
Journal:  Sleep Breath       Date:  2009-07-23       Impact factor: 2.816

Review 9.  A practical guide to the therapy of narcolepsy and hypersomnia syndromes.

Authors:  Emmanuel J M Mignot
Journal:  Neurotherapeutics       Date:  2012-10       Impact factor: 7.620
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.